The largest database of trusted experimental protocols

Celltiter glo 3d reagent

Manufactured by Promega
Sourced in United States, Germany, Italy, France, Ireland

CellTiter-Glo 3D reagent is a luminescent cell viability assay that quantifies ATP, which indicates the presence of metabolically active cells. The reagent is designed for use with 3D cell culture models.

Automatically generated - may contain errors

101 protocols using celltiter glo 3d reagent

1

Sorafenib Cytotoxicity in Tumor Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
sorafenib tosylate (Cat. No. S-8502) was purchased from LC Laboratories, dissolved in DMSO at 10 mM aliquots, and stored at −20°C. Tumor organoids were plated at a density of 5 × 103 cells in 15 μL BME2 droplets in order to form organoids. At day 6, sorafenib was added to the medium, and cell viability was measured after 6 days using CellTiter-Glo 3D reagent (Promega). Luminescence was measured on a Synergy H1 Multi-Mode Reader (BioTek Instruments). Results were normalized to vehicle (=100% DMSO). Curve fitting was performed using Prism (GraphPad) software and the nonlinear regression equation. All experiments were performed at least two times in duplicate. Results are shown as mean ± SEM.
+ Open protocol
+ Expand
2

Spheroid Viability Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spheroids were gently pipetted from agarose gels. Individual spheroids in 100μL complete cortical media were transferred to an opaque-walled, clear bottom 96-well plate, using a 200μL pipette with the tip cut off to accommodate the spheroid. 100μL of CellTiter-Glo 3D Reagent (Promega Life Sciences) was added to each well. The plate was wrapped in aluminum foil and placed on a shaker for 10 minutes to induce lysis. The luminescence was measured using a Cytation5 (Biotek).
+ Open protocol
+ Expand
3

Assessing Pt(IV)-M13 Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
For addressing Pt(IV)-M13 cytotoxicity, we plated and incubated overnight 1500 individual cells/well in F-bottom black-chimney 96-well plates (Costar) in Neurobasal medium and incubated overnight. Next, cells were treated with serial dilutions of each platinum compound. After 96 h incubation, cell viability was assessed using the Cell-Titer Glo 3D reagent (Promega). Luminescence was measured in a Perkin Elmer 1450 MicroBeta TriLux Microplate Scintillation Luminescence Counter.
+ Open protocol
+ Expand
4

Radiosensitivity of Carcinoma Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumoroids derived from carcinoma (MEC and AdCC) were harvested and subcultured in 48-well plates as described above. Then, 3 days after seeding, the organoids were irradiated using the X-Rad320 (Precision X-Ray, North Branford, CT, USA). Separate culture plates were used for different radiation doses ranging from 0 to 10 Gy. Media were changed after radiation, and organoids were cultured for another 4 days. Cell viability was measured via the evaluation of ATP levels using the CellTiter-Glo 3D reagent (Promega), according to the manufacturer’s protocol. The results were normalized to baseline (0%, staurosporin 1 μM) and positive (100%, 0 Gy) controls.
+ Open protocol
+ Expand
5

Adenoma Organoid Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The adenoma organoids transfected with PLOD3-siRNA were used to detect cell viability. The CellTiter-Glo® 3D Reagent (Promega, G9681) was used to dissolve the matrigel. The adenoma organoid suspension was equally distributed to opaque-walled multiwell plates (Corning, REF3603). The volume of CellTiter-Glo® 3D Reagent equal to the volume of cell culture medium was added to each well and then the content was incubated for 30 min at room temperature. Cell viability was calculated based on ATP content of each well.
+ Open protocol
+ Expand
6

Organoid Viability Assay for Drug Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viability of the tumor and normal organoids following drug treatment was performed as previously described [23 (link)]; see additional details in the Supplementary Methods. Briefly, organoids were collected with an organoid harvesting solution (Cultrex, R&D Systems, Minneapolis, MN, USA) and digested to single cells with TrypLE Express (Gibco, Waltham, MA, USA). Single cells were suspended in AdDE+++ medium with 10% Matrigel and seeded at a density of 10,000 cells/well in an ultra-low attachment 96-well U-bottom white plate. After 1–4 days, the organoids were exposed to carboplatin (1 µM), cisplatin (1 µM), paclitaxel (10 nM), bevacizumab (1 µM), gemcitabine (100 nM), topotecan (100 nM) or different combinations for 72 h at 37 °C. At the end of the incubation, an equal volume of the CellTiter-Glo 3D reagent (Promega, Madison, WI, USA) was added to each well and incubated for 25 min at room temperature. Luminescence, reflective of cell viability, was measured using a Gen5 Microplate Reader (BioTek, Winooski, VT, USA). All the tests were conducted in triplicate and the data were normalized to untreated controls (set at 100% viability).
+ Open protocol
+ Expand
7

Nanoparticle Synthesis and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare nanoparticles, poly-L-arginine hydrochloride (M w = 5800 Da) was provided by Polypeptide Therapeutic Solutions S. L. (Valencia, Spain) and low molecular weight hyaluronic acid (M w ≈ 20 kDa) was purchased from Lifecore® Biomedical (Chaska, USA). AmberLite® IRA 900 Cl ion exchange resin, dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt-Cl 2 , M w = 380.17 Da) and silver nitrate (AgNO 3 , M w = 169.97 Da) were purchased from Sigma-Aldrich® (Saint-Quentin-Fallavier, France). Sodium hydroxide (NaOH) was purchased from Acros Organics (Thermo Fisher Scientific, Illkirch, France). Oxaliplatin solution (Hospira®, Meudon, France) was a kind gift from the Hospital of Lyon, France. Deionized water (Milli-Q water) was obtained from a Milli-Q plus system (Merck-Millipore, Darmstadt, Germany). A CellTiter Glo® 3D reagent was purchased from Promega Corporation (Madison, USA). To prepare microwells, agarose standard (ROTI®Garose) was purchased from Carl Roth® (Karlsruhe, Germany) and the Norland Optical Adhesive 81 (NOA) glue was provided by Norland Products Inc. (Cranbury, USA). For coverslip silanisation, 3-aminopropyltriethoxysilane 99% (APTS) came from AcroSeal® (Heysham, United Kingdom) and glacial acetic acid was supplied by VWR PROLABO® Chemicals (Fontenay-sous-Bois, France).
+ Open protocol
+ Expand
8

Tumor Organoid Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor organoids were plated as single cells in a 96-well plate at a density of 1 × 104 cells in 10 μL Matrigel droplets. Before treatment, cells were allowed to recover and form organoids for 2 to 3 days. At day 3, 6-MP at a final concentration of 2.5 µM or 5-FU at concentrations of 1.25, 2.5 and 5 µM or in combination was added to the medium, and cell viability was assessed after 5 day using CellTiter-Glo 3D reagent (#G9682, Promega). Luminescence was measured on Varioskan Microplate Reader (ThermoFisher Scientific). Results were normalized to DMSO control. All experiments were performed twice in quadruplicate.
+ Open protocol
+ Expand
9

Spheroid Assay for OVCA420 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
OVCA420* cells stably expressing inducible TIGAR shRNAs (TRIPZ inducible lentiviral shRNAs were purchased from Dharmacon, US) were established by selection with puromycin after viral transduction. Stable cells were treated with 1 µg/mL doxycycline for 72 h to induce expression of shRNAs. Then 3000 cells/well were seeded into 96-well plates (plates were pre-coated with 100 µL 1.5% (wt/vol) agarose) and treated with vehicle or different concentrations of olaparib for 10 days. At the end of the experiment, pictures of spheroid were taken under a microscope and cell viability was measured with CellTiter-Glo 3D reagent (Promega Corporation).
+ Open protocol
+ Expand
10

Cell Viability Assay with CellTiter-Glo3D

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 and U-251 MG cells were seeded at a density of 3.0 × 103 cells/90 μL per well in 96-well plates (3596; Corning, NY, USA) and treated with the test compounds (10 μL per well) 24 h after seeding. After 3 d, CellTiter-Glo® 3D Reagent (Promega, Madison, WI, USA) was added to each well at an equivalent volume to the cell culture medium in the well, mixed by shaking for 5 min at room temperature, and incubated for 25 min at 37 °C under 5% CO2. The 100 μL supernatants were then transferred in technical replicates to 96-well white plates (136101; Thermo Fisher Scientific), and their luminescence was measured using a luminometer (GloMax® Discover System; Promega).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!